AGP Executive Report
Last update: 2 hours agoFDA/DEA Drug Policy: HHS and the FDA backed DEA’s move to start temporary scheduling for certain kratom-related 7-OH substances, with a public comment request on what 7-OH threshold counts as an imminent public-safety hazard. Infectious Disease Watch: CDC updated U.S. measles totals to 2,170 cases—already near last year’s record—with more months of peak transmission still ahead. Public Health & Safety: DC’s July 4 response logged 6,009 911 calls and 699 medical contacts around the National Mall, with illegal or hazardous fireworks driving the most emergency calls. Access, Coverage, and Politics: California’s governor’s race is sharpening over immigrant healthcare and state-funded coverage for low-income residents, while ProPublica reports immigrant minors’ deportations have surged under the Trump administration. Clinical Care Capacity: Children’s Health expanded its Level IV NICU in Dallas by 15% (52 to 60 beds) to meet rising demand for specialized neonatal care. Health Tech & Devices: Neo Medical launched its Neo Instant MIS Access™ platform for minimally invasive spine surgery, and Vivos won FDA approval to begin a first-in-human feasibility study of RadioGel® for non-resectable papillary thyroid cancer. AI in Medicine: Utah’s AI chatbot refill program is drawing debate over whether AI is ready to handle prescription refill tasks traditionally done by clinicians.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
